Anthony S. Gibney - May 16, 2025 Form 4 Insider Report for Aura Biosciences, Inc. (AURA)

Role
Chief Financial and Business Officer
Signature
/s/ Conor Kilroy, as Attorney-in-Fact
Stock symbol
AURA
Transactions as of
May 16, 2025
Transactions value $
$237,177
Form type
4
Date filed
5/20/2025, 05:34 PM
Previous filing
May 16, 2025
Next filing
Jun 4, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Gibney Anthony S Chief Financial and Business Officer C/O AURA BIOSCIENCES, INC., 80 GUEST STREET, BOSTON /s/ Conor Kilroy, as Attorney-in-Fact 2025-05-20 0001750132

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AURA Common Stock Purchase $245K +50K +591.58% $4.90 58.5K May 16, 2025 Direct F1
transaction AURA Common Stock Sale -$7.82K -1.52K -2.6% $5.15 56.9K May 16, 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AURA Common Stock Warrants (right to buy) Purchase +12.5K 12.5K May 16, 2025 Common Stock 12.5K $4.90 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On May 16, 2025, the Reporting Person purchased 50,000 shares of the Issuer's common stock and a warrant to purchase 12,500 shares of the Issuer's common stock at a purchase price of $4.90 in an underwritten public offering.
F2 The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

Remarks:

Chief Financial and Business Officer